pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 1
JANX-007
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$JANXJanux Therapeutics, Inc.
0 catalysts
Phase 1
JANX-008
Head And Neck Squamous Cell Carcinoma (HNSC)
$JANXJanux Therapeutics, Inc.
0 catalysts
Phase 2
JBI-778
Adenoid Cystic Carcinoma (ACC)
Jubilant Therapeutics Inc
0 catalysts
Phase 2
← prev
page 24 of 62
next →
131
Pain89
Neurology1
JBI-802
Neuroendocrine Tumors
Jubilant Therapeutics Inc
0 catalysts
Phase 1
JBZ-001
Diffuse Large B-Cell Lymphoma
Jabez Biosciences Inc
0 catalysts
Phase 2
JIN-A02
Non-Small Cell Lung Cancer
J Ints Bio Co Ltd
0 catalysts
Phase 1
JMKX-1899
Colorectal Cancer
HUYA Bioscience International LLC
0 catalysts
Phase 3
JNJ-1900
Head And Neck Squamous Cell Carcinoma (HNSC)
$JNJJOHNSON & JOHNSON
0 catalysts
Phase 1
JPH-034
Glioma
J-Pharma Co Ltd
0 catalysts
Phase 2
JWATM-204
Hepatocellular Carcinoma
Eureka Therapeutics Inc
0 catalysts
Phase 1
JZP-3507
Ependymoma
$JAZZJazz Pharmaceuticals plc
0 catalysts
Phase 1
JZP-898
Gastroesophageal (GE) Junction Carcinomas
$JAZZJazz Pharmaceuticals plc
0 catalysts
Phase 2
Jankistomig
Solid Tumor
Ottimo Pharma Ltd
0 catalysts
Phase 2
KB-707
Metastatic Melanoma
$KRYSKrystal Biotech, Inc.
0 catalysts
Preclinical
KBX-114
Gynecological Cancer
Kaida BioPharma Inc
0 catalysts
Preclinical
KFPH-013
Unspecified Cancer
Jiangsu Carephar Pharmaceutical Co Ltd
0 catalysts
Phase 1
KGX-101
Solid Tumor
Shanghai KangaBio Co Ltd
0 catalysts
Preclinical
KIN-102
Solid Tumor
Kinimmune Inc
0 catalysts
Phase 2
KITE-363
Diffuse Large B-Cell Lymphoma
Kite Pharma Inc
0 catalysts
Phase 2
KITE-753
Diffuse Large B-Cell Lymphoma
$GILDGILEAD SCIENCES, INC.
0 catalysts
Phase 1
KK-2269
Solid Tumor
Kyowa Kirin Co Ltd
0 catalysts
Preclinical
KLS-3021
Breast Cancer
Kolon Life Science Inc
0 catalysts
Preclinical
KMD-111
Breast Cancer
KMD Bio Co Ltd
0 catalysts
Phase 1
KN-01
Breast Cancer
PendreaBio Inc
0 catalysts
Preclinical
KOP-101
Prostate Cancer
KOP Therapeutics Corp
0 catalysts
Phase 1
KPG-121
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Kangpu Biopharmaceuticals Ltd
0 catalysts
Phase 1
KQB-548
Metastatic Colorectal Cancer
Kumquat Biosciences Inc
0 catalysts
Phase 2
KSQ-001
Head And Neck Squamous Cell Carcinoma (HNSC)
KSQ Therapeutics Inc
0 catalysts
Phase 2
KSQ-004
Acral Lentiginous Melanoma
KSQ Therapeutics Inc
0 catalysts
Phase 1
KST-6051
Metastatic Colorectal Cancer
$KGKestrel Group Ltd
0 catalysts